|Slideshows|May 25, 2017

Interesting Endo: Osteoporosis & Thyroid Cancer

Our May list includes a new treatment for osteoporosis, predictors of thyroid cancer recurrence, and fast-acting vs conventional insulin for T1DM.

We present a selection of interesting endocrinology articles for the month of May in the following slides. See the slide legends for links to the article summaries.

Related Content

FDA News Month in Review: January 2025 | Image Credit: HCPLive

FDA News Recap: March 2025

ByVictoria Johnson

March 31st 2025

FDA Approves Celltrion’s Denosumab Biosimilars for Bone Loss Indications

ByVictoria Johnson

March 4th 2025

USPSTF Finalizes 2024 Osteoporosis Screening Recommendations

ByVictoria Johnson

January 14th 2025

Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis

ByMatthew J. Budoff, MD,Connor Iapoce

December 15th 2024

Jean-Yves Reginster, MD, PhD, Outstanding Professor of Epidemiology, Public Health and Health Economics, and Professor of Bioethics and Societal Medicine, and Honorary Chair of the Bone and Cartilage Metabolism Unit, at the University of Liège

Denosumab Biosimilar Demonstrates Equivalent Efficacy, Safety in Phase 3 Trial

ByVictoria Johnson

December 3rd 2024